ADXN | Addex Therapeutics Ltd Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Revenue	1.61M	1.42M	2.92M	3.61M	2.76M	6.04M	499.89K	17.33K	40.30K	85.40K	91.76K	121.09K	2.82M	1.98M	4.09M	26.81M	486.93K	4.74M
Cost of Revenue	6.94M	14.62M	12.82M	10.37M	230.10K	144.17K	29.76K	17.33K	40.30K	85.40K	91.76K	1.27M	27.99M	31.16M	N/A	N/A	-156.03K	N/A
Gross Profit	-5.32M	-13.20M	-9.90M	-6.76M	2.53M	5.90M	470.13K	N/A	N/A	N/A	N/A	-1.15M	-25.16M	-29.19M	4.09M	26.81M	642.96K	4.74M
Operating Expenses	11.89M	21.94M	18.42M	15.86M	17.37M	7.47M	3.24M	3.14M	2.64M	1.80M	14.46M	27.01M	5.81M	35.57M	47.56M	51.68M	38.11M	25.76M
Selling, General & Admin	7.20M	7.30M	5.14M	5.15M	4.26M	4.72M	2.20M	1.52M	1.57M	1.55M	6.47M	12.85M	6.73M	6.43M	7.60M	7.55M	10.77M	N/A
Research & Development	2.75M	14.67M	12.84M	10.37M	12.45M	2.37M	841.31K	819.33K	761.22K	258.06K	2.22M	4.76M	4.76M	31.16M	39.96M	44.19M	12.21M	9.77M
Other Operating Expenses	1.94M	-22.52K	444.00K	336.68K	648.16K	382.99K	197.67K	799.70K	311.82K	-9.44K	5.77M	9.40M	-919.55K	-2.02M	N/A	-67.33K	25.90M	15.98M
Operating Income	-10.28M	-20.52M	-15.51M	-12.24M	-14.83M	-1.42M	-3.24M	-3.13M	-3.87M	-1.80M	-14.46M	-27.01M	-30.97M	-33.60M	-43.05M	-24.87M	-37.62M	-20.90M
Other Expenses / Income	-274.93K	-284.01K	154.00K	-615.33K	-176.45K	-220.17K	-45.35K	-19.79K	-1.56M	748.35K	-3.23K	-8.41K	-167.17K	-47.56K	85.75M	2.81M	2.54M	355.32K
Before Tax Income	-10.56M	-20.80M	-15.35M	-12.86M	-14.78M	-1.64M	-3.28M	-3.15M	-4.20M	-1.77M	-14.46M	-26.61M	-31.14M	-33.65M	42.69M	-22.07M	-35.09M	-20.54M
Income Tax Expenses	N/A	123.91K	116.38K	207.76K	429.01K	1.00	N/A	6.92K	152.21K	-21.68K	3.23K	-398.93K	72.20K	97.25K	171.13M	3.31M	2.54M	346.91K
Net Income	-10.56M	-20.80M	-15.35M	-12.86M	-14.78M	-1.64M	-3.28M	-3.15M	-4.20M	-1.77M	-14.46M	-26.61M	-31.14M	-33.65M	-42.69M	-22.07M	-35.09M	-20.54M
Interest Expenses	21.61K	48.90K	63.01K	69.50K	128.52K	220.17K	45.35K	6.92K	152.21K	N/A	N/A	N/A	239.37K	144.81K	N/A	501.88K	8.54K	30.45K
Basic Shares Outstanding	74.31M	45.18M	34.12M	26.68M	26.43M	23.29M	12.94M	11.41M	10.85M	9.98M	9.07M	7.91M	1.24M	986.06K	955.78K	956.03K	836.15K	476.53K
Diluted Shares Outstanding	74.31M	45.18M	34.12M	26.68M	26.43M	23.29M	12.94M	11.41M	10.85M	9.98M	9.07M	7.91M	1.24M	986.06K	955.78K	956.03K	836.15K	476.53K
EBITDA	-10.23M	-20.23M	-14.94M	-12.41M	-14.32M	-1.51M	-3.22M	-3.12M	-2.61M	-1.71M	-13.79M	-24.87M	-28.05M	-30.56M	-39.86M	-19.55M	-33.26M	-17.99M
EBITDA Margin	-634.16%	-1,422.11%	-512.34%	-343.51%	-518.25%	-24.94%	-644.10%	-17,979.05%	-6,488.51%	-1,998.26%	-15,026.90%	-20,542.67%	-993.33%	-1,547.10%	-974.30%	-72.92%	-6,830.55%	-379.66%
EBIT	-10.53M	-20.63M	-15.17M	-12.58M	-14.22M	-1.42M	-3.24M	-3.14M	-3.90M	-1.80M	-14.46M	-27.01M	-30.83M	-33.40M	128.44M	-18.26M	-32.53M	-20.17M
EBIT Margin	-653.13%	-1,450.43%	-520.26%	-348.24%	-514.80%	-23.57%	-647.15%	-18,094.17%	-9,676.67%	-2,103.57%	-15,756.97%	-22,306.25%	-1,091.91%	-1,691.08%	3,139.71%	-68.11%	-6,681.22%	-425.57%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31